Risperidone

Results: 185



#Item
111Pharmaceuticals and Medical Devices Safety Information No. 313 May 2014

Pharmaceuticals and Medical Devices Safety Information No. 313 May 2014

Add to Reading List

Source URL: www.pmda.go.jp

Language: English - Date: 2014-07-01 00:54:18
112DATE: November 6, 2009 FROM: Dianne Murphy, MD, FAAP Director, Office of Pediatric Therapeutics Office of the Commissioner U.S. Food and Drug Administration SUBJECT: Overview of the December 8, 2009: Meeting of the Pedia

DATE: November 6, 2009 FROM: Dianne Murphy, MD, FAAP Director, Office of Pediatric Therapeutics Office of the Commissioner U.S. Food and Drug Administration SUBJECT: Overview of the December 8, 2009: Meeting of the Pedia

Add to Reading List

Source URL: www.fda.gov

Language: English
113BULLETIN # 52 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on September 14, 2006.

BULLETIN # 52 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on September 14, 2006.

Add to Reading List

Source URL: www.gov.mb.ca

Language: English - Date: 2014-07-17 11:44:11
114Injectable Antipsychotics Request for Prior Authorization Fax completed form to Cenpatico at[removed]Upon receipt of all necessary information, Cenpatico will contact you by fax or phone within one business day. No

Injectable Antipsychotics Request for Prior Authorization Fax completed form to Cenpatico at[removed]Upon receipt of all necessary information, Cenpatico will contact you by fax or phone within one business day. No

Add to Reading List

Source URL: www.medicaid.ms.gov.php53-14.ord1-1.websitetestlink.com

Language: English - Date: 2014-03-25 15:58:49
115HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RISPERDAL® safely and effectively. See full prescribing information for RISPERDAL®. RISPERDAL® (risperidone) tabl

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RISPERDAL® safely and effectively. See full prescribing information for RISPERDAL®. RISPERDAL® (risperidone) tabl

Add to Reading List

Source URL: www.fda.gov

Language: English
116Ask the Medical Advisory Board  Letters In each issue, a member of TSA’s Medical Advisory Board addresses medical questions that affect people with TS and their families. This issue’s contributor is Gerald Erenberg,

Ask the Medical Advisory Board Letters In each issue, a member of TSA’s Medical Advisory Board addresses medical questions that affect people with TS and their families. This issue’s contributor is Gerald Erenberg,

Add to Reading List

Source URL: tsa-usa.org

Language: English - Date: 2011-08-03 15:45:41
117ASKATCHEWAN DRUG INFORMATION SERVICE College of Pharmacy and Nutrition y University of Saskatchewan 110 Science Place y Saskatoon SK y S7N 5C9 y www.usask.ca/druginfo Depot neuroleptics: Injection sites, techniques and c

ASKATCHEWAN DRUG INFORMATION SERVICE College of Pharmacy and Nutrition y University of Saskatchewan 110 Science Place y Saskatoon SK y S7N 5C9 y www.usask.ca/druginfo Depot neuroleptics: Injection sites, techniques and c

Add to Reading List

Source URL: medsask.usask.ca

Language: English - Date: 2013-03-14 12:11:15
118Microsoft Word - nov-dec2011_12[removed]final.doc

Microsoft Word - nov-dec2011_12[removed]final.doc

Add to Reading List

Source URL: www.dhs.wisconsin.gov

Language: English - Date: 2011-12-14 16:15:33
119Ask The  MEDICAL ADVISORY BOARD In each issue, a member of TSA’s Medical Advisory Board addresses medical questions that affect people with TS and their families. This issue’s contributor is Samuel H. Zinner M.D., As

Ask The MEDICAL ADVISORY BOARD In each issue, a member of TSA’s Medical Advisory Board addresses medical questions that affect people with TS and their families. This issue’s contributor is Samuel H. Zinner M.D., As

Add to Reading List

Source URL: tsa-usa.org

Language: English - Date: 2011-08-03 15:47:38
120®  Treating disruptive behavior in people with dementia Antipsychotic drugs are usually not the best choice

® Treating disruptive behavior in people with dementia Antipsychotic drugs are usually not the best choice

Add to Reading List

Source URL: consumerhealthchoices.org

Language: English - Date: 2013-09-11 13:57:24